History focuses on the pattern (both legs vs one, onset, progression), associated symptoms (pain, numbness, color change, swelling), and risk factors (smoking, diabetes, thyroid disease, medications)
Some researchers adjust dosing based on body weight, using approximately 30 to 50mcg of total KLOW per kilogram of body weight as a rough target for moderate dosing
One notable finding from meta-analyses: cagrilintide demonstrated the lowest odds ratios for nausea, vomiting, and diarrhea when compared to other incretin-based therapies including semaglutide and tirzepatide
Theres a chance youll see them offered on a multitude of telemed platforms
10(7): p
Currently, there is insufficient evidence to demonstrate that oral glutathione is safe during pregnancy or while nursing